BACKGROUND: Composite end points are common in clinical trials. OBJECTIVE: To describe how composite outcomes are used, constructed, and reported in cardiovascular trials and to evaluate the contribution of individual end points to the composite estimate of effect in those trials. DESIGN: Review of 2-group, parallel-design, randomized cardiovascular trials that used composite end points and were published in 14 clinical journals from 1 January 2000 to 1 January 2007. SETTING: Published randomized trials in cardiovascular medicine and surgery. PARTICIPANTS: Two-group, parallel-design trials published in 14 leading general medical, cardiology, and cardiothoracic surgery journals from 1 January 2000 to 1 January 2007. MEASUREMENTS: The types a...
<p>Composite cardiovascular outcomes in the Scottish cohort: results contain participants and partic...
Background: A number of composite outcomes have been developed to capture the perspective of the pat...
Composite endpoints are commonly used as the primary measure of efficacy in heart failure clinical t...
BACKGROUND: Composite end points are common in clinical trials. OBJECTIVE: To describe how composite...
BACKGROUND: Because composite end points augment event rates, they are often thought to increase sta...
Background Because composite end points augment event rates, they are often thought to increase stat...
A composite end point is often used as the primary end point to assess the efficacy of a new treatme...
ObjectivesOur purpose was to evaluate the heterogeneity and validity of composite end points, major ...
Background – A composite endpoint is often used as the primary endpoint to assess the efficacy of a ...
Objectives: To systematically assess the type of outcomes selected and the prevalence of patient rep...
© 2020 The Author(s). Background: Composite measures combine data to provide a comprehensive vie...
Composite endpoints are commonly used as the primary measure of efficacy in heart failure clinical t...
Composite endpoints are commonly used as the primary measure of efficacy in heart failure clinical t...
Composite endpoints are commonly used as the primary measure of efficacy in heart failure clinical t...
Objectives: To examine patients’ perspectives regarding composite endpoints and the utility patients...
<p>Composite cardiovascular outcomes in the Scottish cohort: results contain participants and partic...
Background: A number of composite outcomes have been developed to capture the perspective of the pat...
Composite endpoints are commonly used as the primary measure of efficacy in heart failure clinical t...
BACKGROUND: Composite end points are common in clinical trials. OBJECTIVE: To describe how composite...
BACKGROUND: Because composite end points augment event rates, they are often thought to increase sta...
Background Because composite end points augment event rates, they are often thought to increase stat...
A composite end point is often used as the primary end point to assess the efficacy of a new treatme...
ObjectivesOur purpose was to evaluate the heterogeneity and validity of composite end points, major ...
Background – A composite endpoint is often used as the primary endpoint to assess the efficacy of a ...
Objectives: To systematically assess the type of outcomes selected and the prevalence of patient rep...
© 2020 The Author(s). Background: Composite measures combine data to provide a comprehensive vie...
Composite endpoints are commonly used as the primary measure of efficacy in heart failure clinical t...
Composite endpoints are commonly used as the primary measure of efficacy in heart failure clinical t...
Composite endpoints are commonly used as the primary measure of efficacy in heart failure clinical t...
Objectives: To examine patients’ perspectives regarding composite endpoints and the utility patients...
<p>Composite cardiovascular outcomes in the Scottish cohort: results contain participants and partic...
Background: A number of composite outcomes have been developed to capture the perspective of the pat...
Composite endpoints are commonly used as the primary measure of efficacy in heart failure clinical t...